Datametrex a money printing machine… and now Screenpro??Following the excellent news this morning from Datametrex which mentions having 20M in cash, what can we assume for Screenpro? Datametrex had 13M in cash in Q3 and now 20M, so 7M for Q4 only. This cash is mainly for COVID test kits. A very strong Q4. Screenpro follows by doing the tests. I would like to see an Update from Screenpro on this subject to inform its shareholders as Datametrex has just done.
Always very happy to be heavily invested in Datametrex and Screenpro.
Datametrex Reports $20M in Cash on the Balance Sheet from Operation
2022-01-18 03:01 ET - News Release
Toronto, Ontario--(Newsfile Corp. - January 18, 2022) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company currently has approximately $20M in cash and cash equivalent (marketable securities) on the balance sheet.
Over the last few quarters, the Company has had strong positive cash flow from its operations, which is attributed to the current strong balance sheet. The cash balance is twenty times what it was valued in the same period of 2019. It is currently equivalent to approximately $0.056 per share with the Company's current market cap of approximately $85M.
Datametrex believes there will be continuous growth in revenue and profitability from its operations, which will generate stronger positive cash flow for the Company in 2022, resulting in a stronger balance sheet and cash position. The entire team at Datametrex is fully dedicated to maximizing the share value for our shareholders.
"We are pleased with the great start to the year as we continue to make every effort to improve revenue and find efficiencies from the efforts made over the years. We look forward to delivering on greater cash flow in 2022," said Marshall Gunter, CEO of the Company.
"As we continue to grow the revenue and look to expand the Company, we will also focus on operating as efficiently as possible, as it will allow us to meet the Company's objectives and produce value for our investors," said Andrew Ryu, Chairman of the Company.
About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (https://www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.
For further information, please contact:
Marshall Gunter - CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com
Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.